Could a common steroid save lives in severe sepsis and lung failure?
NCT ID NCT07511582
First seen Apr 18, 2026 · Last updated Apr 28, 2026 · Updated 4 times
Summary
This study tests whether the steroid methylprednisolone can improve organ function and reduce deaths in critically ill patients with a severe inflammatory condition called hyperinflammatory phenotype, often seen in sepsis and acute respiratory distress syndrome (ARDS). About 150 adults in intensive care will receive either a high or low dose of the drug or a placebo for up to 7 days. Researchers will monitor organ function, survival, and recovery for 30 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.